Compare COR & PSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COR | PSX |
|---|---|---|
| Founded | 2001 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.5B | 63.9B |
| IPO Year | 2001 | 2011 |
| Metric | COR | PSX |
|---|---|---|
| Price | $281.67 | $179.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 19 |
| Target Price | ★ $390.62 | $165.63 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | 0.77% | ★ 2.93% |
| EPS Growth | 5.71 | ★ 116.23 |
| EPS | ★ 11.27 | 0.51 |
| Revenue | ★ $321,332,819,000.00 | $132,376,000,000.00 |
| Revenue This Year | $8.89 | $15.71 |
| Revenue Next Year | $6.75 | N/A |
| P/E Ratio | ★ $25.01 | $349.49 |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $244.82 | $118.07 |
| 52 Week High | $377.54 | $190.61 |
| Indicator | COR | PSX |
|---|---|---|
| Relative Strength Index (RSI) | 54.84 | 53.05 |
| Support Level | $261.29 | $167.73 |
| Resistance Level | $326.95 | $183.06 |
| Average True Range (ATR) | 5.17 | 5.35 |
| MACD | 3.51 | -0.39 |
| Stochastic Oscillator | 85.15 | 54.45 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.